
Results
46
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
46 companies
Grifols
Market Cap: €6.8b
Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.
GRF
€11.20
7D
1.9%
1Y
19.1%
PharmaEssentia
Market Cap: NT$183.1b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$495.00
7D
1.2%
1Y
-10.8%
China Resources Pharmaceutical Group
Market Cap: HK$28.3b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.51
7D
-1.3%
1Y
-16.9%
Hypera
Market Cap: R$14.8b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$23.33
7D
-0.1%
1Y
30.2%
Lotus Pharmaceutical
Market Cap: NT$74.2b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$282.00
7D
1.3%
1Y
6.6%
Harmony Biosciences Holdings
Market Cap: US$2.2b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$37.38
7D
-2.0%
1Y
7.5%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥14.6b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥9.03
7D
-2.0%
1Y
-26.3%
Bora Pharmaceuticals
Market Cap: NT$61.0b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$492.00
7D
-1.1%
1Y
-21.0%
Organon
Market Cap: US$1.9b
Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$7.24
7D
0.8%
1Y
-53.1%
Pacific Shuanglin Bio-pharmacy
Market Cap: CN¥13.0b
Engages in research, development, production, and sales of blood products in China and internationally.
000403
CN¥13.69
7D
-3.2%
1Y
-17.9%
Hugel
Market Cap: ₩2.5t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩235,000.00
7D
3.5%
1Y
-12.0%
Neuren Pharmaceuticals
Market Cap: AU$2.4b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$18.91
7D
-4.0%
1Y
55.0%
Alvotech
Market Cap: US$1.6b
Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.
ALVO
US$5.00
7D
-4.9%
1Y
-62.3%
Collegium Pharmaceutical
Market Cap: US$1.4b
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$45.53
7D
-8.6%
1Y
54.3%
KPC PharmaceuticalsInc
Market Cap: CN¥9.5b
A pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People’s Republic of China and internationally.
600422
CN¥12.56
7D
-0.8%
1Y
-19.6%
Shanghai Haohai Biological Technology
Market Cap: HK$10.2b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$24.30
7D
-4.8%
1Y
-5.1%
L&C BIOLTD
Market Cap: ₩1.5t
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.
A290650
₩62,400.00
7D
-0.3%
1Y
130.3%
Genomma Lab Internacional. de
Market Cap: Mex$17.5b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
LAB B
Mex$17.93
7D
-0.8%
1Y
-30.7%
Strides Pharma Science
Market Cap: ₹83.0b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.
STAR
₹900.75
7D
-1.1%
1Y
29.0%
Tong Ren Tang Technologies
Market Cap: HK$5.7b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.44
7D
-0.4%
1Y
-12.4%
Emergent BioSolutions
Market Cap: US$657.0m
A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.
EBS
US$12.51
7D
0.6%
1Y
21.2%
Newron Pharmaceuticals
Market Cap: CHF 476.1m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 23.85
7D
0.8%
1Y
170.7%
Medy-Tox
Market Cap: ₩859.2b
Operates as a biopharmaceutical company in South Korea.
A086900
₩122,400.00
7D
4.1%
1Y
-1.9%
DongKook Pharmaceutical
Market Cap: ₩764.1b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩17,080.00
7D
-2.0%
1Y
4.8%
Dong-A Socio Holdings
Market Cap: ₩693.1b
Engages in the pharmaceutical business in South Korea.
A000640
₩107,700.00
7D
-2.3%
1Y
6.0%
Zevra Therapeutics
Market Cap: US$469.5m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$8.34
7D
-6.0%
1Y
-2.9%
Blau Farmacêutica
Market Cap: R$2.5b
A pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.
BLAU3
R$13.91
7D
6.9%
1Y
7.8%
SIGA Technologies
Market Cap: US$449.0m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$6.27
7D
0%
1Y
-0.9%
Clinuvel Pharmaceuticals
Market Cap: AU$638.1m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$12.71
7D
-0.5%
1Y
6.0%
Beximco Pharmaceuticals
Market Cap: ৳45.5b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.
BXPHARMA
৳101.90
7D
-6.0%
1Y
30.3%
Abeona Therapeutics
Market Cap: US$287.8m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$5.31
7D
-2.6%
1Y
-11.8%
JBM (Healthcare)
Market Cap: HK$2.2b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.65
7D
-2.6%
1Y
39.5%
Essex Bio-Technology
Market Cap: HK$2.2b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$3.81
7D
-2.1%
1Y
33.2%
Egyptian International Pharmaceutical Industries
Market Cap: ج.م13.1b
Manufactures and sells pharmaceutical ampoules in Egypt and internationally.
PHAR
ج.م77.50
7D
1.7%
1Y
67.8%
Laboratorio Reig Jofre
Market Cap: €218.1m
A pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food.
RJF
€2.68
7D
3.9%
1Y
4.3%
Coherus Oncology
Market Cap: US$165.6m
A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
CHRS
US$1.37
7D
3.0%
1Y
-17.5%